UNSPSC 51461514: Boneset

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers DG4F8T839X and M9VVZ08EKQ (leaf and root), and which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 35980 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Asterales, Family Asteraceae, Genus Eupatorium L. (thoroughwort), Species Eupatorium perfoliatum L., more commonly known as common BONESET.

UNSPSC 51461514 Boneset is a Commodity code representing individual pharmaceutical products sourced through state and local cooperative purchasing vehicles. State and local governments procure bonesets as active pharmaceutical ingredients or finished OTC formulations through multistate purchasing alliances that aggregate demand across participating jurisdictions and their healthcare, correctional, and social-service facilities. The work involves establishing framework contracts with pharmaceutical manufacturers and wholesalers to supply identified products at negotiated pricing, with vendors certifying compliance with current Good Manufacturing Practices, the Drug Supply Chain Security Act, and FDA requirements. Issuing bodies are primarily state procurement offices administering multistate cooperative purchasing alliances; the Minnesota Department of Administration's Office of State Procurement, acting through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), represents the dominant active buyer in recent solicitations.

MMCAP, which serves participating state and local government facilities across Minnesota and Oregon, posted a Request for Proposal on January 20, 2026 (due March 26, 2026) to establish multiple-award contracts for generic multi-source pharmaceuticals and OTC products. The procurement requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), submit pricing in designated formats (flat price, net price, or WAC-minus structures), and maintain contractual relationships with at least two of the three wholesalers with chargeback systems in place. Evaluation weights pricing competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing, administrative compliance, EDI capability, and the 3 percent administrative fee requirement. The resulting contracts are effective July 1, 2026 for a two-year term with optional extensions at MMCAP's discretion, with performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials.